nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—ATP4B—digestive system—colon cancer	0.0213	0.234	CbGeAlD
Esomeprazole—ATP4B—liver—colon cancer	0.0159	0.174	CbGeAlD
Esomeprazole—ATP4A—epithelium—colon cancer	0.0122	0.134	CbGeAlD
Esomeprazole—ATP4A—renal system—colon cancer	0.0113	0.124	CbGeAlD
Esomeprazole—ATP4A—digestive system—colon cancer	0.00929	0.102	CbGeAlD
Esomeprazole—ATP4A—liver—colon cancer	0.00692	0.0759	CbGeAlD
Esomeprazole—Pantoprazole—ABCB1—colon cancer	0.00513	0.39	CrCbGaD
Esomeprazole—Omeprazole—ABCB1—colon cancer	0.00418	0.318	CrCbGaD
Esomeprazole—Lansoprazole—ABCB1—colon cancer	0.00382	0.291	CrCbGaD
Esomeprazole—CYP2C19—digestive system—colon cancer	0.00324	0.0356	CbGeAlD
Esomeprazole—CYP2C19—vagina—colon cancer	0.00286	0.0314	CbGeAlD
Esomeprazole—CYP2C19—liver—colon cancer	0.00242	0.0265	CbGeAlD
Esomeprazole—CYP3A4—renal system—colon cancer	0.00234	0.0256	CbGeAlD
Esomeprazole—CYP3A4—digestive system—colon cancer	0.00192	0.021	CbGeAlD
Esomeprazole—CYP3A4—liver—colon cancer	0.00143	0.0157	CbGeAlD
Esomeprazole—Urinary tract infection—Capecitabine—colon cancer	0.00133	0.00148	CcSEcCtD
Esomeprazole—Osteoarthritis—Methotrexate—colon cancer	0.00132	0.00147	CcSEcCtD
Esomeprazole—Confusional state—Irinotecan—colon cancer	0.00131	0.00146	CcSEcCtD
Esomeprazole—Nervous system disorder—Vincristine—colon cancer	0.00131	0.00146	CcSEcCtD
Esomeprazole—Thrombocytopenia—Vincristine—colon cancer	0.00131	0.00146	CcSEcCtD
Esomeprazole—Haematuria—Capecitabine—colon cancer	0.0013	0.00145	CcSEcCtD
Esomeprazole—Anaphylactic shock—Irinotecan—colon cancer	0.0013	0.00145	CcSEcCtD
Esomeprazole—Chest pain—Fluorouracil—colon cancer	0.0013	0.00145	CcSEcCtD
Esomeprazole—Myalgia—Fluorouracil—colon cancer	0.0013	0.00145	CcSEcCtD
Esomeprazole—Infection—Irinotecan—colon cancer	0.00129	0.00144	CcSEcCtD
Esomeprazole—Hyperhidrosis—Vincristine—colon cancer	0.00129	0.00144	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Capecitabine—colon cancer	0.00129	0.00144	CcSEcCtD
Esomeprazole—Epistaxis—Capecitabine—colon cancer	0.00129	0.00144	CcSEcCtD
Esomeprazole—Discomfort—Fluorouracil—colon cancer	0.00128	0.00143	CcSEcCtD
Esomeprazole—Shock—Irinotecan—colon cancer	0.00128	0.00143	CcSEcCtD
Esomeprazole—Nervous system disorder—Irinotecan—colon cancer	0.00128	0.00142	CcSEcCtD
Esomeprazole—Agranulocytosis—Capecitabine—colon cancer	0.00127	0.00142	CcSEcCtD
Esomeprazole—Thrombocytopenia—Irinotecan—colon cancer	0.00127	0.00142	CcSEcCtD
Esomeprazole—Anorexia—Vincristine—colon cancer	0.00127	0.00142	CcSEcCtD
Esomeprazole—Irritability—Methotrexate—colon cancer	0.00126	0.0014	CcSEcCtD
Esomeprazole—Hyperhidrosis—Irinotecan—colon cancer	0.00126	0.0014	CcSEcCtD
Esomeprazole—Confusional state—Fluorouracil—colon cancer	0.00126	0.0014	CcSEcCtD
Esomeprazole—Bradycardia—Capecitabine—colon cancer	0.00125	0.00139	CcSEcCtD
Esomeprazole—Anaphylactic shock—Fluorouracil—colon cancer	0.00125	0.00139	CcSEcCtD
Esomeprazole—Anorexia—Irinotecan—colon cancer	0.00124	0.00138	CcSEcCtD
Esomeprazole—Infection—Fluorouracil—colon cancer	0.00124	0.00138	CcSEcCtD
Esomeprazole—Rhinitis—Capecitabine—colon cancer	0.00123	0.00137	CcSEcCtD
Esomeprazole—Hepatitis—Capecitabine—colon cancer	0.00122	0.00137	CcSEcCtD
Esomeprazole—Nervous system disorder—Fluorouracil—colon cancer	0.00122	0.00136	CcSEcCtD
Esomeprazole—Thrombocytopenia—Fluorouracil—colon cancer	0.00122	0.00136	CcSEcCtD
Esomeprazole—Hypoaesthesia—Capecitabine—colon cancer	0.00122	0.00136	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Vincristine—colon cancer	0.00122	0.00136	CcSEcCtD
Esomeprazole—Pharyngitis—Capecitabine—colon cancer	0.00122	0.00136	CcSEcCtD
Esomeprazole—Tachycardia—Fluorouracil—colon cancer	0.00122	0.00136	CcSEcCtD
Esomeprazole—Urinary tract disorder—Capecitabine—colon cancer	0.00121	0.00135	CcSEcCtD
Esomeprazole—Insomnia—Vincristine—colon cancer	0.00121	0.00135	CcSEcCtD
Esomeprazole—Oedema peripheral—Capecitabine—colon cancer	0.00121	0.00135	CcSEcCtD
Esomeprazole—Connective tissue disorder—Capecitabine—colon cancer	0.0012	0.00134	CcSEcCtD
Esomeprazole—Urethral disorder—Capecitabine—colon cancer	0.0012	0.00134	CcSEcCtD
Esomeprazole—Paraesthesia—Vincristine—colon cancer	0.0012	0.00134	CcSEcCtD
Esomeprazole—Breast disorder—Methotrexate—colon cancer	0.00119	0.00133	CcSEcCtD
Esomeprazole—Anorexia—Fluorouracil—colon cancer	0.00119	0.00133	CcSEcCtD
Esomeprazole—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00119	0.00133	CcSEcCtD
Esomeprazole—Visual impairment—Capecitabine—colon cancer	0.00118	0.00132	CcSEcCtD
Esomeprazole—Insomnia—Irinotecan—colon cancer	0.00118	0.00131	CcSEcCtD
Esomeprazole—Paraesthesia—Irinotecan—colon cancer	0.00117	0.0013	CcSEcCtD
Esomeprazole—Decreased appetite—Vincristine—colon cancer	0.00116	0.0013	CcSEcCtD
Esomeprazole—Dyspnoea—Irinotecan—colon cancer	0.00116	0.00129	CcSEcCtD
Esomeprazole—Erythema multiforme—Capecitabine—colon cancer	0.00116	0.00129	CcSEcCtD
Esomeprazole—Somnolence—Irinotecan—colon cancer	0.00116	0.00129	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Vincristine—colon cancer	0.00115	0.00129	CcSEcCtD
Esomeprazole—Fatigue—Vincristine—colon cancer	0.00115	0.00129	CcSEcCtD
Esomeprazole—Eye disorder—Capecitabine—colon cancer	0.00114	0.00128	CcSEcCtD
Esomeprazole—Dyspepsia—Irinotecan—colon cancer	0.00114	0.00128	CcSEcCtD
Esomeprazole—Tinnitus—Capecitabine—colon cancer	0.00114	0.00127	CcSEcCtD
Esomeprazole—Constipation—Vincristine—colon cancer	0.00114	0.00127	CcSEcCtD
Esomeprazole—Pain—Vincristine—colon cancer	0.00114	0.00127	CcSEcCtD
Esomeprazole—Asthma—Methotrexate—colon cancer	0.00114	0.00127	CcSEcCtD
Esomeprazole—Flushing—Capecitabine—colon cancer	0.00114	0.00127	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00113	0.00127	CcSEcCtD
Esomeprazole—Decreased appetite—Irinotecan—colon cancer	0.00113	0.00126	CcSEcCtD
Esomeprazole—Insomnia—Fluorouracil—colon cancer	0.00113	0.00126	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Irinotecan—colon cancer	0.00112	0.00125	CcSEcCtD
Esomeprazole—Fatigue—Irinotecan—colon cancer	0.00112	0.00125	CcSEcCtD
Esomeprazole—Paraesthesia—Fluorouracil—colon cancer	0.00112	0.00125	CcSEcCtD
Esomeprazole—Pancreatitis—Methotrexate—colon cancer	0.00112	0.00125	CcSEcCtD
Esomeprazole—Pain—Irinotecan—colon cancer	0.00111	0.00124	CcSEcCtD
Esomeprazole—Constipation—Irinotecan—colon cancer	0.00111	0.00124	CcSEcCtD
Esomeprazole—Dyspnoea—Fluorouracil—colon cancer	0.00111	0.00124	CcSEcCtD
Esomeprazole—Somnolence—Fluorouracil—colon cancer	0.00111	0.00124	CcSEcCtD
Esomeprazole—Immune system disorder—Capecitabine—colon cancer	0.00111	0.00124	CcSEcCtD
Esomeprazole—Mediastinal disorder—Capecitabine—colon cancer	0.0011	0.00123	CcSEcCtD
Esomeprazole—Chills—Capecitabine—colon cancer	0.0011	0.00123	CcSEcCtD
Esomeprazole—Dyspepsia—Fluorouracil—colon cancer	0.0011	0.00122	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Vincristine—colon cancer	0.00109	0.00122	CcSEcCtD
Esomeprazole—Decreased appetite—Fluorouracil—colon cancer	0.00108	0.00121	CcSEcCtD
Esomeprazole—Alopecia—Capecitabine—colon cancer	0.00108	0.00121	CcSEcCtD
Esomeprazole—Pancytopenia—Methotrexate—colon cancer	0.00108	0.00121	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00108	0.0012	CcSEcCtD
Esomeprazole—Mental disorder—Capecitabine—colon cancer	0.00107	0.0012	CcSEcCtD
Esomeprazole—Feeling abnormal—Irinotecan—colon cancer	0.00107	0.0012	CcSEcCtD
Esomeprazole—Malnutrition—Capecitabine—colon cancer	0.00107	0.00119	CcSEcCtD
Esomeprazole—Dysuria—Methotrexate—colon cancer	0.00107	0.00119	CcSEcCtD
Esomeprazole—Neutropenia—Methotrexate—colon cancer	0.00107	0.00119	CcSEcCtD
Esomeprazole—Pain—Fluorouracil—colon cancer	0.00106	0.00119	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Irinotecan—colon cancer	0.00106	0.00119	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Methotrexate—colon cancer	0.00106	0.00118	CcSEcCtD
Esomeprazole—Abdominal pain—Vincristine—colon cancer	0.00106	0.00118	CcSEcCtD
Esomeprazole—Body temperature increased—Vincristine—colon cancer	0.00106	0.00118	CcSEcCtD
Esomeprazole—Flatulence—Capecitabine—colon cancer	0.00105	0.00117	CcSEcCtD
Esomeprazole—Erectile dysfunction—Methotrexate—colon cancer	0.00105	0.00117	CcSEcCtD
Esomeprazole—Dysgeusia—Capecitabine—colon cancer	0.00104	0.00117	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Methotrexate—colon cancer	0.00104	0.00116	CcSEcCtD
Esomeprazole—Back pain—Capecitabine—colon cancer	0.00103	0.00115	CcSEcCtD
Esomeprazole—Abdominal pain—Irinotecan—colon cancer	0.00103	0.00115	CcSEcCtD
Esomeprazole—Body temperature increased—Irinotecan—colon cancer	0.00103	0.00115	CcSEcCtD
Esomeprazole—Feeling abnormal—Fluorouracil—colon cancer	0.00103	0.00115	CcSEcCtD
Esomeprazole—Muscle spasms—Capecitabine—colon cancer	0.00103	0.00114	CcSEcCtD
Esomeprazole—Infestation—Methotrexate—colon cancer	0.00102	0.00113	CcSEcCtD
Esomeprazole—Infestation NOS—Methotrexate—colon cancer	0.00102	0.00113	CcSEcCtD
Esomeprazole—Depression—Methotrexate—colon cancer	0.00101	0.00113	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00101	0.00112	CcSEcCtD
Esomeprazole—Vision blurred—Capecitabine—colon cancer	0.001	0.00112	CcSEcCtD
Esomeprazole—Tremor—Capecitabine—colon cancer	0.000999	0.00112	CcSEcCtD
Esomeprazole—Renal failure—Methotrexate—colon cancer	0.000998	0.00111	CcSEcCtD
Esomeprazole—Stomatitis—Methotrexate—colon cancer	0.00099	0.00111	CcSEcCtD
Esomeprazole—Ill-defined disorder—Capecitabine—colon cancer	0.000989	0.0011	CcSEcCtD
Esomeprazole—Urticaria—Fluorouracil—colon cancer	0.000989	0.0011	CcSEcCtD
Esomeprazole—Conjunctivitis—Methotrexate—colon cancer	0.000987	0.0011	CcSEcCtD
Esomeprazole—Anaemia—Capecitabine—colon cancer	0.000985	0.0011	CcSEcCtD
Esomeprazole—Body temperature increased—Fluorouracil—colon cancer	0.000984	0.0011	CcSEcCtD
Esomeprazole—Hypersensitivity—Vincristine—colon cancer	0.000984	0.0011	CcSEcCtD
Esomeprazole—Haematuria—Methotrexate—colon cancer	0.000968	0.00108	CcSEcCtD
Esomeprazole—Malaise—Capecitabine—colon cancer	0.000961	0.00107	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Methotrexate—colon cancer	0.000961	0.00107	CcSEcCtD
Esomeprazole—Epistaxis—Methotrexate—colon cancer	0.000958	0.00107	CcSEcCtD
Esomeprazole—Vertigo—Capecitabine—colon cancer	0.000958	0.00107	CcSEcCtD
Esomeprazole—Hypersensitivity—Irinotecan—colon cancer	0.000958	0.00107	CcSEcCtD
Esomeprazole—Asthenia—Vincristine—colon cancer	0.000958	0.00107	CcSEcCtD
Esomeprazole—Leukopenia—Capecitabine—colon cancer	0.000954	0.00107	CcSEcCtD
Esomeprazole—Agranulocytosis—Methotrexate—colon cancer	0.000948	0.00106	CcSEcCtD
Esomeprazole—Palpitations—Capecitabine—colon cancer	0.000942	0.00105	CcSEcCtD
Esomeprazole—Asthenia—Irinotecan—colon cancer	0.000933	0.00104	CcSEcCtD
Esomeprazole—Cough—Capecitabine—colon cancer	0.00093	0.00104	CcSEcCtD
Esomeprazole—Hypertension—Capecitabine—colon cancer	0.000921	0.00103	CcSEcCtD
Esomeprazole—Hypersensitivity—Fluorouracil—colon cancer	0.000917	0.00102	CcSEcCtD
Esomeprazole—Diarrhoea—Vincristine—colon cancer	0.000913	0.00102	CcSEcCtD
Esomeprazole—Hepatitis—Methotrexate—colon cancer	0.000912	0.00102	CcSEcCtD
Esomeprazole—Arthralgia—Capecitabine—colon cancer	0.000908	0.00101	CcSEcCtD
Esomeprazole—Myalgia—Capecitabine—colon cancer	0.000908	0.00101	CcSEcCtD
Esomeprazole—Chest pain—Capecitabine—colon cancer	0.000908	0.00101	CcSEcCtD
Esomeprazole—Pharyngitis—Methotrexate—colon cancer	0.000905	0.00101	CcSEcCtD
Esomeprazole—Anxiety—Capecitabine—colon cancer	0.000905	0.00101	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000901	0.00101	CcSEcCtD
Esomeprazole—Urinary tract disorder—Methotrexate—colon cancer	0.0009	0.00101	CcSEcCtD
Esomeprazole—Discomfort—Capecitabine—colon cancer	0.000897	0.001	CcSEcCtD
Esomeprazole—Urethral disorder—Methotrexate—colon cancer	0.000894	0.000998	CcSEcCtD
Esomeprazole—Diarrhoea—Irinotecan—colon cancer	0.00089	0.000993	CcSEcCtD
Esomeprazole—Dry mouth—Capecitabine—colon cancer	0.000888	0.000991	CcSEcCtD
Esomeprazole—Dizziness—Vincristine—colon cancer	0.000883	0.000986	CcSEcCtD
Esomeprazole—Pruritus—Fluorouracil—colon cancer	0.000881	0.000984	CcSEcCtD
Esomeprazole—Visual impairment—Methotrexate—colon cancer	0.000879	0.000981	CcSEcCtD
Esomeprazole—Confusional state—Capecitabine—colon cancer	0.000877	0.00098	CcSEcCtD
Esomeprazole—Infection—Capecitabine—colon cancer	0.000864	0.000965	CcSEcCtD
Esomeprazole—Erythema multiforme—Methotrexate—colon cancer	0.000862	0.000962	CcSEcCtD
Esomeprazole—Dizziness—Irinotecan—colon cancer	0.00086	0.00096	CcSEcCtD
Esomeprazole—Shock—Capecitabine—colon cancer	0.000856	0.000956	CcSEcCtD
Esomeprazole—Nervous system disorder—Capecitabine—colon cancer	0.000853	0.000953	CcSEcCtD
Esomeprazole—Eye disorder—Methotrexate—colon cancer	0.000852	0.000951	CcSEcCtD
Esomeprazole—Diarrhoea—Fluorouracil—colon cancer	0.000852	0.000951	CcSEcCtD
Esomeprazole—Thrombocytopenia—Capecitabine—colon cancer	0.000852	0.000951	CcSEcCtD
Esomeprazole—Tinnitus—Methotrexate—colon cancer	0.00085	0.000949	CcSEcCtD
Esomeprazole—Tachycardia—Capecitabine—colon cancer	0.000849	0.000948	CcSEcCtD
Esomeprazole—Vomiting—Vincristine—colon cancer	0.000849	0.000948	CcSEcCtD
Esomeprazole—Skin disorder—Capecitabine—colon cancer	0.000845	0.000944	CcSEcCtD
Esomeprazole—Rash—Vincristine—colon cancer	0.000842	0.00094	CcSEcCtD
Esomeprazole—Hyperhidrosis—Capecitabine—colon cancer	0.000841	0.000939	CcSEcCtD
Esomeprazole—Dermatitis—Vincristine—colon cancer	0.000841	0.000939	CcSEcCtD
Esomeprazole—Headache—Vincristine—colon cancer	0.000836	0.000934	CcSEcCtD
Esomeprazole—Anorexia—Capecitabine—colon cancer	0.000829	0.000926	CcSEcCtD
Esomeprazole—Vomiting—Irinotecan—colon cancer	0.000827	0.000923	CcSEcCtD
Esomeprazole—Immune system disorder—Methotrexate—colon cancer	0.000824	0.000919	CcSEcCtD
Esomeprazole—Dizziness—Fluorouracil—colon cancer	0.000823	0.000919	CcSEcCtD
Esomeprazole—Mediastinal disorder—Methotrexate—colon cancer	0.000822	0.000917	CcSEcCtD
Esomeprazole—Rash—Irinotecan—colon cancer	0.00082	0.000915	CcSEcCtD
Esomeprazole—Dermatitis—Irinotecan—colon cancer	0.000819	0.000914	CcSEcCtD
Esomeprazole—Chills—Methotrexate—colon cancer	0.000818	0.000913	CcSEcCtD
Esomeprazole—Headache—Irinotecan—colon cancer	0.000814	0.000909	CcSEcCtD
Esomeprazole—Alopecia—Methotrexate—colon cancer	0.000806	0.0009	CcSEcCtD
Esomeprazole—Mental disorder—Methotrexate—colon cancer	0.000799	0.000892	CcSEcCtD
Esomeprazole—Malnutrition—Methotrexate—colon cancer	0.000794	0.000886	CcSEcCtD
Esomeprazole—Nausea—Vincristine—colon cancer	0.000793	0.000885	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000793	0.000885	CcSEcCtD
Esomeprazole—Vomiting—Fluorouracil—colon cancer	0.000792	0.000884	CcSEcCtD
Esomeprazole—Insomnia—Capecitabine—colon cancer	0.000787	0.000879	CcSEcCtD
Esomeprazole—Rash—Fluorouracil—colon cancer	0.000785	0.000877	CcSEcCtD
Esomeprazole—Dermatitis—Fluorouracil—colon cancer	0.000784	0.000876	CcSEcCtD
Esomeprazole—Paraesthesia—Capecitabine—colon cancer	0.000781	0.000872	CcSEcCtD
Esomeprazole—Headache—Fluorouracil—colon cancer	0.00078	0.000871	CcSEcCtD
Esomeprazole—Dysgeusia—Methotrexate—colon cancer	0.000777	0.000868	CcSEcCtD
Esomeprazole—Dyspnoea—Capecitabine—colon cancer	0.000776	0.000866	CcSEcCtD
Esomeprazole—Nausea—Irinotecan—colon cancer	0.000772	0.000862	CcSEcCtD
Esomeprazole—Back pain—Methotrexate—colon cancer	0.000768	0.000857	CcSEcCtD
Esomeprazole—Dyspepsia—Capecitabine—colon cancer	0.000766	0.000855	CcSEcCtD
Esomeprazole—Decreased appetite—Capecitabine—colon cancer	0.000756	0.000845	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Capecitabine—colon cancer	0.000751	0.000839	CcSEcCtD
Esomeprazole—Fatigue—Capecitabine—colon cancer	0.00075	0.000838	CcSEcCtD
Esomeprazole—Vision blurred—Methotrexate—colon cancer	0.000748	0.000835	CcSEcCtD
Esomeprazole—Constipation—Capecitabine—colon cancer	0.000744	0.000831	CcSEcCtD
Esomeprazole—Pain—Capecitabine—colon cancer	0.000744	0.000831	CcSEcCtD
Esomeprazole—Nausea—Fluorouracil—colon cancer	0.00074	0.000826	CcSEcCtD
Esomeprazole—Ill-defined disorder—Methotrexate—colon cancer	0.000736	0.000822	CcSEcCtD
Esomeprazole—Anaemia—Methotrexate—colon cancer	0.000734	0.000819	CcSEcCtD
Esomeprazole—Feeling abnormal—Capecitabine—colon cancer	0.000717	0.000801	CcSEcCtD
Esomeprazole—Malaise—Methotrexate—colon cancer	0.000716	0.000799	CcSEcCtD
Esomeprazole—Vertigo—Methotrexate—colon cancer	0.000713	0.000796	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Capecitabine—colon cancer	0.000712	0.000794	CcSEcCtD
Esomeprazole—Leukopenia—Methotrexate—colon cancer	0.00071	0.000793	CcSEcCtD
Esomeprazole—Cough—Methotrexate—colon cancer	0.000693	0.000773	CcSEcCtD
Esomeprazole—Urticaria—Capecitabine—colon cancer	0.000691	0.000772	CcSEcCtD
Esomeprazole—Abdominal pain—Capecitabine—colon cancer	0.000688	0.000768	CcSEcCtD
Esomeprazole—Body temperature increased—Capecitabine—colon cancer	0.000688	0.000768	CcSEcCtD
Esomeprazole—Chest pain—Methotrexate—colon cancer	0.000676	0.000754	CcSEcCtD
Esomeprazole—Arthralgia—Methotrexate—colon cancer	0.000676	0.000754	CcSEcCtD
Esomeprazole—Myalgia—Methotrexate—colon cancer	0.000676	0.000754	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000671	0.000749	CcSEcCtD
Esomeprazole—Discomfort—Methotrexate—colon cancer	0.000668	0.000745	CcSEcCtD
Esomeprazole—Confusional state—Methotrexate—colon cancer	0.000653	0.000729	CcSEcCtD
Esomeprazole—Anaphylactic shock—Methotrexate—colon cancer	0.000648	0.000723	CcSEcCtD
Esomeprazole—Infection—Methotrexate—colon cancer	0.000644	0.000718	CcSEcCtD
Esomeprazole—Hypersensitivity—Capecitabine—colon cancer	0.000641	0.000716	CcSEcCtD
Esomeprazole—Nervous system disorder—Methotrexate—colon cancer	0.000635	0.000709	CcSEcCtD
Esomeprazole—Thrombocytopenia—Methotrexate—colon cancer	0.000634	0.000708	CcSEcCtD
Esomeprazole—Skin disorder—Methotrexate—colon cancer	0.000629	0.000702	CcSEcCtD
Esomeprazole—Hyperhidrosis—Methotrexate—colon cancer	0.000626	0.000699	CcSEcCtD
Esomeprazole—Asthenia—Capecitabine—colon cancer	0.000624	0.000697	CcSEcCtD
Esomeprazole—Anorexia—Methotrexate—colon cancer	0.000617	0.000689	CcSEcCtD
Esomeprazole—Pruritus—Capecitabine—colon cancer	0.000616	0.000687	CcSEcCtD
Esomeprazole—Diarrhoea—Capecitabine—colon cancer	0.000595	0.000665	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00059	0.000659	CcSEcCtD
Esomeprazole—Insomnia—Methotrexate—colon cancer	0.000586	0.000654	CcSEcCtD
Esomeprazole—Paraesthesia—Methotrexate—colon cancer	0.000582	0.000649	CcSEcCtD
Esomeprazole—Dyspnoea—Methotrexate—colon cancer	0.000578	0.000645	CcSEcCtD
Esomeprazole—Somnolence—Methotrexate—colon cancer	0.000576	0.000643	CcSEcCtD
Esomeprazole—Dizziness—Capecitabine—colon cancer	0.000575	0.000642	CcSEcCtD
Esomeprazole—Dyspepsia—Methotrexate—colon cancer	0.00057	0.000637	CcSEcCtD
Esomeprazole—Decreased appetite—Methotrexate—colon cancer	0.000563	0.000629	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Methotrexate—colon cancer	0.000559	0.000624	CcSEcCtD
Esomeprazole—Fatigue—Methotrexate—colon cancer	0.000558	0.000624	CcSEcCtD
Esomeprazole—Pain—Methotrexate—colon cancer	0.000554	0.000618	CcSEcCtD
Esomeprazole—Vomiting—Capecitabine—colon cancer	0.000553	0.000618	CcSEcCtD
Esomeprazole—Rash—Capecitabine—colon cancer	0.000549	0.000613	CcSEcCtD
Esomeprazole—Dermatitis—Capecitabine—colon cancer	0.000548	0.000612	CcSEcCtD
Esomeprazole—Headache—Capecitabine—colon cancer	0.000545	0.000609	CcSEcCtD
Esomeprazole—Feeling abnormal—Methotrexate—colon cancer	0.000534	0.000596	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Methotrexate—colon cancer	0.00053	0.000591	CcSEcCtD
Esomeprazole—Nausea—Capecitabine—colon cancer	0.000517	0.000577	CcSEcCtD
Esomeprazole—Urticaria—Methotrexate—colon cancer	0.000515	0.000575	CcSEcCtD
Esomeprazole—Body temperature increased—Methotrexate—colon cancer	0.000512	0.000572	CcSEcCtD
Esomeprazole—Abdominal pain—Methotrexate—colon cancer	0.000512	0.000572	CcSEcCtD
Esomeprazole—Hypersensitivity—Methotrexate—colon cancer	0.000477	0.000533	CcSEcCtD
Esomeprazole—Asthenia—Methotrexate—colon cancer	0.000465	0.000519	CcSEcCtD
Esomeprazole—Pruritus—Methotrexate—colon cancer	0.000458	0.000512	CcSEcCtD
Esomeprazole—Diarrhoea—Methotrexate—colon cancer	0.000443	0.000495	CcSEcCtD
Esomeprazole—Dizziness—Methotrexate—colon cancer	0.000428	0.000478	CcSEcCtD
Esomeprazole—Vomiting—Methotrexate—colon cancer	0.000412	0.00046	CcSEcCtD
Esomeprazole—Rash—Methotrexate—colon cancer	0.000408	0.000456	CcSEcCtD
Esomeprazole—Dermatitis—Methotrexate—colon cancer	0.000408	0.000456	CcSEcCtD
Esomeprazole—Headache—Methotrexate—colon cancer	0.000406	0.000453	CcSEcCtD
Esomeprazole—Nausea—Methotrexate—colon cancer	0.000385	0.00043	CcSEcCtD
